{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:47:44Z","timestamp":1792176464495,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA048169"],"award-info":[{"award-number":["K23DA048169"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ajogmf.2022.100621","type":"journal-article","created":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T12:00:13Z","timestamp":1648382413000},"page":"100621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort"],"prefix":"10.1016","volume":"4","author":[{"given":"Kathleen J.","family":"Koenigs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Distefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-1016","authenticated-orcid":false,"given":"Davida M.","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2022.100621_bib0001","unstructured":"Guttmacher Institute. Substance use during pregnancy. 2022. Available at: http:\/\/www.guttmacher.org\/statecenter\/spibs\/spib_SADP.pdf. Accessed January 26, 2021."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0002","unstructured":"Miranda L, Dixon V, Reyes C. How states handle drug use during pregnancy. ProPublica. 2015. Available at: https:\/\/projects.propublica.org\/graphics\/maternity-drug-policies-by-state. Accessed January 26, 2021."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0003","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/AOG.0b013e31820a6216","article-title":"ACOG Committee Opinion No. 473: substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0004","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0005","unstructured":"American College of Obstetricians and Gynecologists. 2020. Opposition to criminalization of individuals during pregnancy and the postpartum period. Available at: https:\/\/www.acog.org\/clinical-information\/policy-and-position-statements\/statements-of-policy\/2020\/opposition-criminalization-of-individuals-pregnancy-and-postpartum-period. Accessed January 11, 2021."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0006","unstructured":"American Society of Addiction Medicine. Public policy statement on substance use, misuse, and use disorders during and following pregnancy, with an emphasis on opioids. 2017. Available at: https:\/\/www.asam.org\/docs\/default-source\/public-policy-statements\/substance-use-misuse-and-use-disorders-during-and-following-pregnancy.pdf?sfvrsn=644978c2_4. Accessed January 11, 2021."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0007","unstructured":"American Society of Addiction Medicine. Public policy statement on cannabis. 2020. Available at: https:\/\/www.asam.org\/docs\/default-source\/public-policy-statements\/2020-public-policy-statement-on-cannabis.pdf?sfvrsn=aa3c58c2_2. Accessed January 11, 2021."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0008","series-title":"Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants","year":"2018"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0009","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2019.03.022","volume":"221","author":"Ecker","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0010","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM200105313442219","article-title":"Testing poor pregnant women for cocaine\u2013physicians as police investigators","volume":"344","author":"Annas","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0011","series-title":"Substance-exposed infants: state responses to the problem","author":"Young","year":"2009"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0012","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1019734314414","article-title":"A search for guidance: examining prenatal substance exposure protocols","volume":"6","author":"Zellman","year":"2002","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0013","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/00981389.2014.916375","article-title":"Screening, testing, and reporting for drug and alcohol use on labor and delivery: a survey of Maryland birthing hospitals","volume":"53","author":"Miller","year":"2014","journal-title":"Soc Work Health Care"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0014","unstructured":"Goyer E, Hoppe B, Milford C, Puccio J. NPA Position Statement 2017. Perinatal substance use. National Perinatal Association. 2017. Available at: https:\/\/www.nationalperinatal.org\/_files\/ugd\/209d80_6c125977cd764f67933962492fd13b97.pdf. Accessed January 13, 2021."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0015","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199004263221706","article-title":"The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida","volume":"322","author":"Chasnoff","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0016","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2017.11.010","article-title":"Characteristics of drug use among pregnant women in the united states: opioid and non-opioid illegal drug use","volume":"183","author":"Metz","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.chiabu.2003.07.004","article-title":"Patients\u2019 characteristics and providers\u2019 attitudes: predictors of screening pregnant women for illicit substance use","volume":"28","author":"Kerker","year":"2004","journal-title":"Child Abuse Negl"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0018","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/AOG.0000000000001781","article-title":"Neonatal abstinence syndrome and ethical approaches to the identification of pregnant women who use drugs","volume":"129","author":"Terplan","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0019","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3389\/fphar.2018.00961","article-title":"Screening pregnant women and their neonates for illicit drug use: consideration of the integrated technical, medical, ethical, legal, and social issues","volume":"9","author":"Price","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/AOG.0000000000003986","article-title":"Toxicology testing in pregnancy: evaluating the role of social profiling","volume":"136","author":"Perlman","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0021","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/jwh.2006.0070","article-title":"The effect of race on provider decisions to test for illicit drug use in the peripartum setting","volume":"16","author":"Kunins","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0022","doi-asserted-by":"crossref","first-page":"e1379","DOI":"10.1542\/peds.2008-3525","article-title":"Infant race affects application of clinical guidelines when screening for drugs of abuse in newborns","volume":"125","author":"Ellsworth","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0023","doi-asserted-by":"crossref","first-page":"675","DOI":"10.7326\/0003-4819-125-8-199610150-00008","article-title":"The medicalization of race: scientific legitimization of a flawed social construct","volume":"125","author":"Witzig","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0024","unstructured":"Mass.gov. Massachusetts law about recreational marijuana: a compilation of laws, regulations, cases, and web sources on recreational use of marijuana in Massachusetts. 2021. Available at:https:\/\/www.mass.gov\/info-details\/massachusetts-law-about-recreational-marijuana. Accessed February 16, 2021."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0025","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/AOG.0000000000002349","article-title":"Committee Opinion Summary No. 722: marijuana use during pregnancy and lactation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0026","unstructured":"Massachusetts Department of Public Health executive Office of Health and Human Services. Massachusetts department of public health guidelines for community standard for maternal\/newborn screening for alcohol\/substance use. Available at: https:\/\/www.mass.gov\/lists\/maternal-and-newborn-services-circular-letters. Accessed December 18, 2020."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0027","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1542\/peds.2014-3849","article-title":"Improvement in perinatal HIV status documentation in a Massachusetts birth hospital, 2009-2013","volume":"136","author":"Paydar-Darian","year":"2015","journal-title":"Pediatrics"},{"issue":"RR-14","key":"10.1016\/j.ajogmf.2022.100621_bib0028","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"Branson","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/951616","article-title":"Drug testing for newborn exposure to illicit substances in pregnancy: pitfalls and pearls","volume":"2011","author":"Farst","year":"2011","journal-title":"Int J Pediatr"},{"key":"10.1016\/j.ajogmf.2022.100621_bib0030","unstructured":"Khan Y. NYC will end practice of drug testing pregnant patients without written consent. Gothamist. 2020. Available at: https:\/\/gothamist.com\/news\/nyc-will-end-practice-drug-testing-pregnant-patients-without-written-consent?utm_medium=webfeeds&utm_source=feedly. Accessed January 11, 2021."},{"key":"10.1016\/j.ajogmf.2022.100621_bib0031","unstructured":"Sangoi L. \u201cWhatever they do, I'm her comfort, I'm her protector.\u201d How the foster system has become ground zero for the U.S. drug war. Movement for Family Power. 2020. Available at: https:\/\/static1.squarespace.com\/static\/5be5ed0fd274cb7c8a5d0cba\/t\/5eead939ca509d4e36a89277\/1592449422870\/MFP+Drug+War+Foster+System+Report.pdf. Accessed January 11, 2021."}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933322000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933322000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:50:13Z","timestamp":1762905013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933322000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2589933322000635"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100621","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100621"}}